Complex Rehab Technology (CRT) and Orthotics & Prosthetics (O&P) reimbursement is not the same as traditional DME billing.
These are high-dollar, high-risk claims. A single order can exceed $10,000 to $100,000. Documentation is layered and payer-specific. Authorization timelines stretch months. And when reimbursement is delayed, providers feel it immediately.
If you operate in CRT or O&P, you know that reimbursement performance is a financial control system.
Here is what we consistently see, and how to actually improve results.
The Reality of CRT & O&P Reimbursement
CRT and O&P claims face heightened scrutiny. Prepayment reviews are common. First-pass denials are frequent. And unlike hospital billing, these claims are often all-or-nothing.
If one component fails review, the entire claim can be denied.
Extensive Medical Necessity Requirements
CRT and O&P documentation typically requires:
- Detailed physician face-to-face notes
- Functional assessments tied to mobility or ADL limitations
- PT/OT evaluations
- Supplier clinical notes and justification narratives
- Product-specific documentation, such as K-levels or specialty seating rationale
Small inconsistencies (diagnosis mismatches, outdated notes, missing signatures) frequently trigger denials. And there’s also payer variability; requirements for Medicare, state Medicaid programs, managed care organizations, and commercial payers all differ. Documentation that satisfies one payer may be rejected by another.
Long, Unpredictable Timelines
Prior authorizations often take 30 to 90+ days, and additional review or requests for documentation restart the clock.
After delivery, payment may take:
- 60 to 180 days for many payers
- 6 to 9+ months in some Medicaid programs
For providers that incur upfront costs for custom equipment, delayed reimbursements create persistent cash flow pressure.
Why End-to-End Reimbursement Ownership Matters
In CRT and O&P, fragmented revenue cycle management creates risk.
When intake, authorization, documentation review, coding, billing, and appeals are handled by different teams, errors multiply.
End-to-end ownership produces measurable operational advantages, including:
- Error reduction: When one specialized team owns the full process, documentation alignment begins at intake. In turn, downstream denials tied to missing or inconsistent information are reduced significantly.
- Clear accountability: There is no ambiguity about responsibility. The team owns claim outcomes—not just tasks. Issues are identified before delivery or submission, when they are least expensive to fix.
- Faster collections: Specialized CRT teams understand payer-specific rules, timelines, and appeal pathways. Over time, that means less rework and fewer days in AR.
- Operational efficiency: Standardized workflows reduce duplication and rework. Over time, reimbursement becomes more predictable and less volatile.
Driving Down DSO in Complex Rehab: What Works
Improving cash flow in CRT is not about aggressive collections. It is about disciplined control upstream.
Proactive intake validation, payer-specific expertise, strict authorization tracking, and consistent follow-up shift reimbursement from reactive to controlled.
We’ve seen measurable improvement when those disciplines are applied consistently.
Example: Client 2
- 30-Day DSO (Nov 2024): 161.4
- 30-Day DSO (Nov 2025): 58.5
- 60-Day DSO (Nov 2024): 112.3
- 60-Day DSO (Nov 2025): 72.9
Denial percentage dropped from 17% to 8%. Clean claim ratio improved from 83% to 92%.
Collections increased from $212,241 (Nov 2024) to $417,451 (Nov 2025).
Example: Client 2
- Average DSO (Dec 2024 to Dec 2025): 56.5
Denial rate decreased from 23% to 9%. Clean claim ratio improved from 77% to 91%.
Monthly collections increased from $87,723 (Dec 2024) to $182,709 (Dec 2025).
These improvements were driven by control.
Increasing Collections without Increasing Risk
Revenue improvement must not come at the expense of compliance. Specialized CRT reimbursement teams improve paid-to-billed ratios by:
- Validating authorizations against final configurations
- Applying correct HCPCS codes and modifiers
- Anticipating payer edits before submission
Underpayments are actively reconciled against expected allowables. Fee schedule discrepancies, missing components, and pricing errors are identified and appealed.
For Client 1:
- Collection ratio improved from 91% to 94% year-over-year
- 3-month rolling collection ratio increased from 78% to 105%
- Average collection rate (Nov 2024 to Nov 2025): 95%
- Write-off rate: 2%
Revenue increased from $124,865 (Nov 2024) to $485,515 (Nov 2025).
The objective is simple: increase collections while maintaining audit readiness.
Denial Management: From Reactive to Strategic
In CRT and O&P, there are some common denial themes. When intake teams validate high-risk elements upfront, fewer risky claims enter the pipeline. When clinicians are trained on what payers actually deny, not just what policy states, documentation quality improves.
The result is measurable:
- Client 1 denial rate reduced from 17% to 8%
- Client 2 denial rate reduced from 23% to 9%
Denial management becomes preventive, not reactive.
The Role of Leadership and Training
CRT reimbursement environments change constantly. Strong operational leadership owns DSO, denial rates, and paid-to-billed ratios. They prioritize efficient workflows and escalate payer issues thoughtfully.
Ongoing training is essential here—it reinforces updated coding standards, payer policies, and lessons from recent denials.
CRT and O&P Reimbursement Will Remain Complex
Payer scrutiny will not decrease. Documentation requirements will continue evolving. The question is whether your reimbursement performance is controlled or reactive.
If you would like a reimbursement performance review or consultation, Medbill is actively onboarding new CRT and O&P providers.